Eagle Asset Management’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-457,993
| Closed | -$31.1M | – | 670 |
|
|
2019
Q3 | $31.1M | Buy |
457,993
+199,053
| +77% | +$13.7M | 0.16% | 197 |
|
|
2019
Q2 | $15.1M | Buy |
258,940
+27,480
| +12% | +$1.63M | 0.08% | 250 |
|
|
2019
Q1 | $16.2M | Sell |
231,460
-465
| -0.2% | -$34.5K | 0.09% | 239 |
|
|
2018
Q4 | $14.9M | Sell |
231,925
-16,402
| -7% | -$1.15M | 0.09% | 238 |
|
|
2018
Q3 | $17.4M | Sell |
248,327
-8,371
| -3% | -$490K | 0.08% | 258 |
|
|
2018
Q2 | $12.9M | Sell |
256,698
-42,761
| -14% | -$1.7M | 0.07% | 292 |
|
|
2018
Q1 | $9.37M | Sell |
299,459
-30,166
| -9% | -$1M | 0.05% | 326 |
|
|
2017
Q4 | $11.2M | Sell |
329,625
-21,222
| -6% | -$677K | 0.06% | 311 |
|
|
2017
Q3 | $11.2M | Sell |
350,847
-28,626
| -8% | -$903K | 0.06% | 322 |
|
|
2017
Q2 | $12.4M | Buy |
379,473
+58,920
| +18% | +$1.87M | 0.07% | 305 |
|
|
2017
Q1 | $10.1M | Buy |
320,553
+2,122
| +0.7% | +$62.8K | 0.06% | 331 |
|
|
2016
Q4 | $9.36M | Buy |
318,431
+27,365
| +9% | +$834K | 0.06% | 331 |
|
|
2016
Q3 | $8.42M | Buy |
+291,066
| New | +$8.11M | 0.06% | 345 |
|
Eagle Asset Management's GHDX Position: Q4 2019 in Review
Eagle Asset Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 457,993 shares — an estimated $31.1M sold.
Eagle Asset Management first reported a position in GHDX in Q3 2016 and held it in 13 quarters. The position peaked at $31.1M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Eagle Asset Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Eagle Asset Management sold 457,993 Genomic Health, Inc. shares in Q4 2019, an estimated $31.1M.
- Eagle Asset Management first reported a position in Genomic Health, Inc. in Q3 2016 and held it in 13 quarters.
- Eagle Asset Management's Genomic Health, Inc. position peaked at $31.1M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Eagle Asset Management's 13F filing for Q4 2019, filed 7 Feb 2020.